Rapid Nutrition CEO to Join Stakeholder Board for Prestigious Osteoarthritis Prevention Study, Furthering Commitment to Women’s Health

London, United Kingdom – 28 February 2024 – Rapid Nutrition PLC (Euronext Growth: ALRPD): Rapid Nutrition, a global leader in premium nutrition products, is pleased to announce that Simon St Ledger, CEO of Rapid Nutrition, has been invited to join the stakeholder board for the groundbreaking Osteoarthritis Prevention Study (TOPS).

Following Rapid Nutrition's recent selection as a key partner in TOPS led by Wake Forest University, the inclusion of Simon St Ledger on the stakeholder board further solidifies the company's commitment to advancing scientific research and promoting women's health on a global scale.

TOPS, a comprehensive five-year initiative funded by $17.1 million from esteemed organizations such as the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the Arthritis Foundation, and the Centers for Disease Control and Prevention, aims to investigate the potential preventive effects of weight loss and exercise against osteoarthritis in women.

"The opportunity to contribute to such an important study alongside esteemed colleagues is truly an honour," said Simon St Ledger, CEO of Rapid Nutrition. "I am excited to collaborate with the stakeholder board to support the study team and drive forward this vital research that holds promise for improving women's health globally."

The stakeholder board, comprised of experts in various fields relevant to the study, will provide strategic guidance and oversight throughout the duration of TOPS. Their collective expertise will ensure that the study meets its objectives and delivers impactful findings in the field of osteoarthritis prevention.

Moreover, this collaboration positions Rapid Nutrition to potentially expand its distribution channels and revenue streams in major markets, such as the US. With its flagship SystemLS meal replacements already recognised for their efficacy in supporting weight management, the insights gleaned from TOPS could enhance Rapid Nutrition's product offerings, catering to the evolving needs of consumers in the burgeoning weight loss industry.

According to Market Research, the demand or Weight Loss is expected to rise in the coming years as consumers become more conscious to improve overall health and well-being by reducing excess body weight, managing body composition, and promoting a healthy lifestyle.

Key Takeaway

These key takeaways underscore Rapid Nutrition's strategic alignment with market trends and its ability to leverage its current initiatives to meet the evolving demands of consumers seeking effective solutions for weight management and overall well-being.

As a renowned provider of premium nutrition products, Rapid Nutrition remains dedicated to leveraging its expertise and resources to support initiatives that empower individuals to lead healthier, more fulfilling lives. Simon St Ledger's participation in the stakeholder board reinforces Rapid Nutrition's pivotal role in shaping the future of preventive healthcare and underscores the company's ongoing efforts to make a meaningful impact in the health and wellness sector.

For more information about Rapid Nutrition PLC and its product offerings, including market insights, please visit www.rnplc.com.

About Rapid Nutrition

Rapid Nutrition is a leading health and wellness company committed to providing innovative solutions for a healthier world. With a focus on research-backed formulas, we empower individuals to optimize their well-being and face life's challenges with confidence.

Investor Relations Contact:






This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.

This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).

Subscribe for Updates